Good evening :)
Switch to
Place Order

Arvee Laboratories (India) Ltd

ARVEE
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹117 cr, stock is ranked 1,836
High RiskStock is 4.73x as volatile as Nifty
106.751.75 (+1.67%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹117 cr, stock is ranked 1,836
High RiskStock is 4.73x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
44.06
PB RatioPB Ratio
6.29
Dividend YieldDiv. Yield
Sector PESector PE
24.51
Sector PBSector PB
3.29
Sector Div YldSctr Div Yld
1.52%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Arvee Laboratories provides specialty chemical products. The Company is primarily engaged in manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201820192020202148.0155.2545.7747.961.092.262.222.67
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent EventsAll events 

Reply to Clarification- Financial results 
Announced OnAug 2, 2021

The Exchange had sought clarification from Arvee Laboratories (India) Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. | Download

The Exchange had sought clarification from Arvee Laboratories (India) Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. | Download

Disclosure under SEBI Takeover Regulations 
Announced OnJul 29, 2021

Arvee Laboratories (India) Limited has submitted to the Exchange a copy of Disclosure in form B under Regulation 7 of SEBI (Prohibition of Insider Trading) Regulations, 2015. | Download

Arvee Laboratories (India) Limited has submitted to the Exchange a copy of Disclosure in form B under Regulation 7 of SEBI (Prohibition of Insider Trading) Regulations, 2015. | Download

Press Release 
Announced OnJul 24, 2021

publication of results for quarter ended on 30.6.2021 | Download

publication of results for quarter ended on 30.6.2021 | Download

See all events